Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells

Cancer Science

Volumn 102, Issue 8, 2011, Pages 1493-1500

  Hase, Tetsunari ^a   Sato, Mitsuo ^a   Yoshida, Kenya ^a   Girard, Luc ^d   Takeyama, Yoshihiro ^a   Horio, Mihoko ^a   Elshazley, Momen ^a   Oguri, Tomoyo ^a   Sekido, Yoshitaka ^a,b   Shames, David S ^c   Gazdar, Adi F ^d   Minna, John D ^d   Kondo, Masashi ^a   Hasegawa, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c GENENTECH INC   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPITHELIAL CELL ADHESION MOLECULE;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; UPREGULATION;

ANTIGENS, NEOPLASM; APOPTOSIS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS;

EID: 79960395521     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01973.x     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2007; 2: 327-43.
3. Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Annu Rev Med 2003; 54: 73-87.
4. Mitsudomi T. Advances in target therapy for lung cancer. Jpn J Clin Oncol 2010; 40: 101-6.
5. Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 2010; 10: 241-53.
6. Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A 1979; 76: 1438-42.
7. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96: 417-23.
8. Went P, Vasei M, Bubendorf L et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006; 94: 128-35.
9. Gires O, Bauerle PA. EpCAM as a target in cancer therapy. J Clin Oncol 2010; 28: e239-40. author reply e41-2.
10. Schmidt M, Scheulen ME, Dittrich C et al. An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Ann Oncol 2010; 21: 275-82.
11. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 2007; 171: 386-95.
12. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004; 23: 5748-58.
13. Osta WA, Chen Y, Mikhitarian K et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004; 64: 5818-24.
14. Maetzel D, Denzel S, Mack B et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009; 11: 162-71.
15. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
16. Tai KY, Shiah SG, Shieh YS et al. DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene 2007; 26: 3989-97.
17. Ramirez RD, Sheridan S, Girard L et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004; 64: 9027-34.
18. Gandhi J, Zhang J, Xie Y et al. Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS ONE 2009; 4: e4576.
19. Takeyama Y, Sato M, Horio M et al. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 2010; 296: 216-24.
20. Sato M, Vaughan MB, Girard L et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006; 66: 2116-28.
21. Wenqi D, Li W, Shanshan C et al. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer. J Cancer Res Clin Oncol 2009; 135: 1277-85.
22. Motti ML, Califano D, Baldassarre G et al. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Carcinogenesis 2005; 26: 1021-34.
23. Weinstein IB. Cancer. Addiction to oncogenes - the Achilles heal of cancer. Science 2002; 297: 63-4.
24. Deng QF, Zhou CC, Su CX. Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer. Respirology 2009; 14: 371-6.
25. Winter MJ, Cirulli V, Briaire-de Bruijn IH, Litvinov SV. Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase. Mol Cell Biochem 2007; 302: 19-26.
26. Vutskits GV, Salmon P, Mayor L et al. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells. Breast Cancer Res Treat 2006; 99: 143-53.
27. Litvinov SV, Balzar M, Winter MJ et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997; 139: 1337-48.
28. Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 2009; 69: 753-7.